Wyeth Receives FDA Approval Of Protonix For Delayed Release Oral Suspension (Medical News Today)
Wyeth Pharmaceuticals, a division of Wyeth (NYSE:WYE), announced that the U.S. Food and Drug Administration (FDA) has approved Protonix (pantoprazole sodium) For Delayed-Release Oral Suspension, a new addition to the Protonix family of prescription medications. [click link for full article]

Rotech Healthcare Announces NASDAQ Deficiency Notice (Business Wire via Yahoo! Finance)
ORLANDO, Fla.----Rotech Healthcare Inc. today announced that it received a NASDAQ Staff Deficiency Letter on November 16, 2007, indicating that the Company fails to comply with the minimum market value of publicly held shares requirement for continued listing on the NASDAQ Global Market set forth in Marketplace Rule 4450.